Jeffrey V. Poulton, EVP, CFO: Alnylam Pharmaceuticals ALNY Sell · Filed 02/17

Trade details

Type: Insider sale
Amount: $695,199.36
Shares · price: 2,242 sh · $310.08 a share
Held after: 59,802 sh
Stock: Alnylam Pharmaceuticals ALNY
Person: Jeffrey V. PoultonEVP, CFO
Trade date: 26/02/13
Filed: 26/02/17
Days to filing: 4 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Alnylam Pharmaceuticals trades, last 26 weeks

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/14~03/15

Jeffrey V. Poulton's recent trades

Jeffrey V. PoultonEVP, CFO
SellAlnylam Pharmaceuticals
Sell
Alnylam Pharmaceuticals
ALNY
$264.9K
818 sh
$264.9K
Filed 03/06
Traded 03/04
Jeffrey V. PoultonEVP, CFO
SellAlnylam Pharmaceuticals
Sell
Alnylam Pharmaceuticals
ALNY
$120.8K
374 sh
$120.8K
Filed 03/06
Traded 03/04
Jeffrey V. PoultonEVP, CFO
SellAlnylam Pharmaceuticals
Sell
Alnylam Pharmaceuticals
ALNY
$99.4K
309 sh
$99.4K
Filed 03/06
Traded 03/04
Jeffrey V. PoultonEVP, CFO
SellAlnylam Pharmaceuticals
Sell
Alnylam Pharmaceuticals
ALNY
$94.5K
291 sh
$94.5K
Filed 03/06
Traded 03/04
Jeffrey V. PoultonEVP, CFO
SellAlnylam Pharmaceuticals
Sell
Alnylam Pharmaceuticals
ALNY
$73.8K
230 sh
$73.8K
Filed 03/06
Traded 03/04

Jeffrey V. Poulton, CFO — sold $695.2K of Alnylam Pharmaceuticals ALNY · 3.6% of holdings | Whalegun